Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Boris jordan - The Real Truth

Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.

Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow margins.

Barchart

EXCLUSIVE: Curaleaf Founder Boris Jordan Says Cannabis Drinks Will Be 50% Of The Industry

The future success of the cannabis industry is directly tied to decriminalization and regulation. That's among the topics being discussed at the 2022 Benzinga Cannabis Capital Conference in Chicago.

Benzinga

[Video] This Is How Billionaire Boris Jordan Thinks The Cannabis Industry Will Look Like In The Future

"I'm always thinking five years ahead, where's my growth going to come from? My personal view is that the United States...

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Who Are The Most Impactful Cannabis Executives Of 2022? Top Award Show Will Determine Who's #1

After the awesome Cannabis Capital Conference in Miami during 4/20 week, Benzinga is ready to go again in Chicago on September 13-14.

Benzinga

Curaleaf Reports Second Quarter 2022 Results, Chairman Boris Jordan Says Fundamentals Are Strong

Recently, Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported its financial and operating results for the second quarter, ended June 30, 2022.

Benzinga

What do we really know about the Russian roots of America’s biggest cannabis company?

Curaleaf could be worth $75bn by 2030. But its US-born chair, Boris Jordan, faces questions over his two decades in Russia

The Guardian - US

Recreational weed sales in NJ neared $25 million in the first month — from only 12 stores

Sales at Curaleaf's cannabis store in Bellmawr, New Jersey, have exploded since recreational sales started April 21, now approaching an annual run rate of $100 million in revenue, the company's executive chairman Boris Jordan told stock analysts this month.

The Philadelphia Inquirer

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: Why This Billionaire Cannabis Exec Is Looking To Europe For Industry's Next Growth Stage

The last decade is a story of the U.S. cannabis industry building to an almost $30-billion business in the face of regulatory opposition, Curaleaf Holdings Inc (OTCQX: CURLF) Executive Chairman Boris Jordan said Wednesday — and Europe is the next growth frontier.

Benzinga

EXCLUSIVE: Curaleaf's Boris Jordan On Next Steps To Legal Cannabis, Why 'We've Never Been Closer Than We Are Now'

The path to federally legal cannabis in the United States is a four- or five-step process that hinges on Congressional support, and the outlook has never been better, Curaleaf Holdings Inc (OTCQX: CURLF) Executive Chairman Boris Jordan told

Benzinga

Senator Nick Scutari Determined To Get New Jersey Marijuana Shops Up & Running, Here's What He Plans Next

On Monday, New Jersey's regulators green-lighted the launch of the state's recreational cannabis market.

Benzinga

Curaleaf Holdings To Report Q1 Results In Anticipation Of New Jersey Legal Cannabis Launch

Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) will report its financial and operating results for the first quarter ended March 31, 2022, after market close on May 9, 2022.

Benzinga

New Jersey Senate To Examine Cannabis Rollout Delays, Marijuana Companies, Advocates Grow Irritated

New Jersey Senate president Nick Scutari (D) called delays in rolling out the state’s legal marijuana market unacceptable and is intending to form a special legislative committee to explore the issue through oversight hearings.

Benzinga

When Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?

Curaleaf Holdings' (OTC:CURLF) founder and chairman Boris Jordan was one of many disappointed cannabis entrepreneurs who did not take the news well.

Benzinga

Frustration Mounts As New Jersey Delays Launch Of Legal Cannabis Market, Curaleaf Chairman Speaks Out

While the New Jersey Cannabis Trade Association appeare to remain optimistic that the state Cannabis Regulatory Commission will "sooner rather than later open the adult-use cannabis market in New Jersey," not everyone is feeling so philosophical.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

An American Success Story, Cannabis Mogul Boris Jordan Of Curaleaf: Meet Our Keynote Speakers

From his beginnings on Wall Street in the 1980s to building and overseeing one of the largest cannabis companies on the East Coast, Boris Jordan, executive chairman at Curaleaf Holdings Inc (OTC: CURLF), has come a long way.

Benzinga

Pricing Pressure, Illegal Cannabis Products – Curaleaf And GTI Explain Impacts On Their Earnings

Cannabis earnings season took off last week mostly to the delight of many marijuana-focused investors when reports from two large multi-state operators – Curaleaf (OTCQX: CURLF) and Green Thumb Industries (OTCQX:

Benzinga

Curaleaf Reports Q4 Revenue, Net Loss Narrows As Revenue Surges 39% YoY To $320M

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported its financial and operating results for the fourth quarter and year ended December 31, 2021.

Benzinga

EXCLUSIVE: Curaleaf's Boris Jordan Responds To Russia-Related Allegations: 'Rumors & Misinformation Spread During Turbulent Times'

Shares of American cannabis giant Curaleaf Holdings Inc (OTC: CURLF) traded down Friday after several Twitter users brought up the Russian and Ukrainian descent of executive chairman Boris Jordan.

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Green Thumb Industries

Curaleaf Holdings, Inc.

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.